Hot Stocks
|
Says there is "so… Says there is "so much uncertainty right now - more uncertain than we have ever seen". Says still seeing strong underlying growth metrics. Says there is too much uncertainty in the business to provide a full-year guide, but feel "very good" about long-term trajectory. Says viewing trends are similar around the world, seeing growth everywhere. Some markets are further along in business maturation. Says Netflix still under 10% of TV viewing, would like to earn more viewing time share. Comments taken from Q4 earnings conference call. ShowHide Related Items >><< - 16:10 Today
- Netflix says past year 'testament' to company's approach
- 16:07 Today
- Netflix says 'very close to being sustainably FCF positive'
- 16:06 Today
- Netflix now targets 20% operating margin in FY21
- 16:04 Today
- Netflix up 7% after Q4 results, Q1 guidance
- 10:13 Today JPMorgan
- JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
- 01/15/21 Citi
- Citi cuts Spotify to Sell with no benefit seen on podcast investments
- 01/15/21 Piper Sandler
- Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
- 01/14/21 Barclays
- Netflix could add 90M Asia-Pacific subs in five years, says Barclays
- 16:03 Today
- Netflix sees Q1 EPS $2.97, consensus $2.10
- 16:01 Today
- Netflix reports Q4 EPS $1.19, consensus $1.39
- 13:40 Today
- Notable companies reporting after market close
- 10/20/20
- Netflix sees Q4 EPS $1.35, consensus 94c
- 01/15/21
- Data suggests Netflix North American usage dipped in Q4, Business Insider says
- 01/06/21
- Netflix raising prices for some UK subscription plans, BBC reports
- 12/15/20
- Netflix streaming experiences outage for over 1,000 users, Reuters says
- 12/07/20
- Netflix sued by Activision over allegedly poaching former CFO, WSJ reports
- 17:50 Today
- Fly Intel: After-Hours Movers
- 15:04 Today
- Fly Intel: What to watch in Netflix earnings report
- 01/15/21
- Spotify plunges after downgrade, report of Apple podcast ambitions
- 01/15/21
- Accolade upgrade, Spotify downgrade among today's top calls on Wall Street
- 12/09/20
- Disney rises as Wall Street analysts get more bullish ahead of investor day
- 12/09/20
- Disney upgrade, Zoom Video downgrade among today's top calls on Wall Street
- 14:49 Today
- Netflix options imply 9.5% move in share price post-earnings
- 12/31/20
- Early notable gainers among liquid option names on December 31st
- 10/26/20
- Early notable gainers among liquid option names on October 26th
- 10/21/20
- Notable open interest changes for October 21st
|
Conference/Events
| ShowHide Related Items >><< - 08:29 Today
- Cocrystal Pharma completes research obligations under Merck agreement
- 07:20 Today
- Atea Pharmaceuticals appoints Jayanthi Wolf as SVP, regulatory affairs
- 01/14/21
- Philips. Merck partner on personalized fertility treatment solutions
- 01/13/21
- Ligand will get $1.5M milestone payment from Merck
- 01/06/21 Citi
- Citi opens 'positive catalyst watch' on Merck
- 01/05/21 Citi
- Citi boosts Merck target to $105, says may be most undervalued in pharma
- 12/22/20 Mizuho
- Autolus, Arcus among top 2021 oncology picks at Mizuho
- 12/21/20 Alliance Global Partners
- Alliance Global Partners keeps Buy on Sellas following data from trials
- 10/27/20
- Merck raises FY20 adjusted EPS view to $5.91-$6.01 from $5.63-$5.78
- 10/27/20
- Merck reports Q3 adjusted EPS $1.74, consensus $1.43
- 10/26/20
- Notable companies reporting before tomorrow's open
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 12/19/20
- Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 12/26/20
- Week in review: How Trump's policies moved stocks
- 12/02/20
- Fly Intel: Wall Street's top stories at midday
- 12/02/20
- Fly Intel: Pre-market Movers
- 11/23/20
- Fly Intel: Wall Street's top stories for Monday
- 10/27/20
- Fly Intel: Pre-market Movers
- 09/08/20
- Moderna slides as analyst says sell on rising COVID vaccine competition
- 07/31/20
- Fly Intel: Pre-market Movers
- 12/23/20
- Merck call volume above normal and directionally bullish
- 10/20/20
- Merck put volume heavy and directionally bearish
- 08/06/20
- Unusually active option classes on open August 6th
- 08/05/20
- Merck call volume above normal and directionally bullish
|
Periodicals
|
The upcoming… The upcoming administration of U.S. President-elect Joe Biden is mulling establishing a White House position centered on competition policy and issued relating to antitrust, Reuters' Diane Bartz and Nandita Bose reports, citing two sources familiar with the matter. Reference Link ShowHide Related Items >><< - 01/11/21
- Gundlach recommends owning emerging markets with deflation hedges
- 01/11/21
- Gundlach says emerging markets in Asia is best equity trade
- 01/11/21
- Gundlach sees inflation rise in May, June being 'massive game-changer'
- 01/11/21
- Gundlach says stimulus allowing market to trade at high valuations
SPY SPDR S&P 500 ETF Trust - 01/07/21 Credit Suisse
- Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
- 11/09/20 JPMorgan
- JPMorgan sees S&P 500 hitting 4,000 by early next year
- 09/01/20
- Fed's Brainard says monetary policy to pivot from stabilization to accommodation
- 08/17/20 Goldman Sachs
- Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
- 01/17/21
- Yellen to say U.S. doesn't seek weaker dollar, WSJ reports
- 01/15/21
- U.K. tightens borders to prevent arrival of new COVID strains, Reuters says
- 01/14/21
- Biden unveils details of $1.9T COVID-19 relief plan, CNBC reports
- 01/14/21
- Biden to release $1.5T stimulus package proposal, Reuters says
SPY SPDR S&P 500 ETF Trust - 11/09/20
- Options markets on track for record option volume
- 09:18 Today
- Overnight activity included 1336 trades in SPX and 72 trades in VIX
- 01/15/21
- Overnight activity included 1151 trades in SPX and 23 trades in VIX
- 01/14/21
- Overnight activity included 587 trades in SPX and 13 trades in VIX
- 01/13/21
- Overnight activity included 965 trades in SPX and 8 trades in VIX
SPY SPDR S&P 500 ETF Trust - 01/15/21
- On the Fly: Weekly ETF Fund Flows
- 01/15/21
- SPDR S&P 500 ETF Trust: Pivot points
- 01/14/21
- SPDR S&P 500 ETF Trust: Pivot points
- 01/15/21
- On The Fly: Weekly technical notes for S&P 500
- 01/08/21
- On The Fly: Weekly technical notes for S&P 500
- 12/31/20
- On The Fly: Weekly technical notes for S&P 500
- 12/28/20
- On The Fly: Weekly technical notes for S&P 500
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< SYRS Syros Pharmaceuticals - 12/06/20
- Syros acquires clinical-stage drug candidate for Acute Promyelocytic Leukemia
- 12/06/20
- Syros Pharmaceuticals presents new data from Phase 2 trial of SY-1425
- 11/04/20
- Syros to present new data from Phase 2 SY-1425 trial at ASH meeting
- 10/25/20
- Syros presents initial data from Phase 1 trial of SY-5609
SRNE Sorrento Therapeutics - 17:09 Today
- Sorrento Therapeutics jumps 10% to $10.40 after COVID data announcement
- 17:09 Today
- Sorrento Therapeutics to present STI-2020 data from mutation survey in COVID
- 12/30/20
- Sorrento submits Marketing Authorization Application to Mexico for COVI-STIX
- 12/22/20
- Sorrento Therapeutics submits EUA to FDA for COVI-STIX rapid test
- 16:43 Today
- Perion Network trading halted, news pending
- 12/07/20
- Perion Network jumps 8% to $8.37 after raising Q4, FY20 guidance
- 11/02/20
- Perion Network, Microsoft renew strategic partnership for four more years
- 07/22/20
- Perion Network to acquire Pub Ocean for up to $22M
- 16:10 Today
- Netflix says past year 'testament' to company's approach
- 16:07 Today
- Netflix says 'very close to being sustainably FCF positive'
- 16:06 Today
- Netflix now targets 20% operating margin in FY21
- 16:04 Today
- Netflix up 7% after Q4 results, Q1 guidance
- 06:37 Today
- Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies
- 01/12/21
- Merus in pacts with medical organizations in Netherlands and Japan for screening
- 01/07/21
- Merus receives fast track designation for Zenocutuzumab from FDA
- 12/17/20
- Merus, Sema4 enter into agreement for Phase 1/2 trial of zenocutuzumab
- 12:00 Today
- Lithium Americas rises 30.6%
- 10:00 Today
- Lithium Americas rises 19.6%
- 09:47 Today
- Lithium Americas rises 15.7%
- 01/11/21
- Lithium Americas falls -9.6%
- 16:09 Today
- J.B. Hunt jumps 3% to $153.00 after Q4 earnings beat
- 16:08 Today
- J.B. Hunt says Q4 revenue growth driven by ICS and Truck segments
- 12/22/20
- J.B. Hunt, University of Arkansas announce $2.25M collaboration on diversity
- 11/30/20
- J.B. Hunt subsidiary acquires Mass Movement
- 01/11/21
- Gevo announces concept of Net-Zero Projects
- 01/06/21
- Gevo pays off Whitebox Convertible Senior Secured Notes
- 01/04/21
- Gevo engages Koch Project Solutions for expansion prokects
- 12/21/20
- Gevo options site for expansion project
- 11/25/20
- Fulton Financial declares special cash dividend
- 11/23/20
- Fulton Financial acquires all outstanding stock of BenefitWorks
- 10/21/20
- Fulton Financial: Previous 2020 guidance withdrawn due to impact from COVID-19
- 10/21/20
- Fulton Financial sees Q4 net interest income $153M-$158M
- 16:10 Today
- eXp World Holdings announces 2-for-1 stock split in form of a dividend
- 01/13/21
- eXp Realty opens in New Brunswick, Manitoba
- 01/07/21
- eXp plans to expand to four new international locations in early 2021
- 12/14/20
- eXp Realty surpasses 40,000 agents globally
- 01/08/21
- CareDx to acquire TransChart, terms not disclosed
- 01/07/21
- CareDx announces exclusive partnership with IDbyDNA
- 01/04/21
- CareDx's AlloSeq HCT wins tender for stem cell transplant surveillance
- 12/01/20
- CareDx announces publication on AlloSure in pediatric patients
- 08:38 Today
- Bionano Genomics' Saphyr System shows improved MDS detection in publication
- 01/15/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 01/14/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 01/13/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 10:13 Today JPMorgan
- JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
- 01/15/21 Citi
- Citi cuts Spotify to Sell with no benefit seen on podcast investments
- 01/15/21 Piper Sandler
- Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
- 01/14/21 Barclays
- Netflix could add 90M Asia-Pacific subs in five years, says Barclays
- 10:50 Today Roth Capital
- Merus price target raised to $32 from $19 at Roth Capital
- 09/02/20 Roth Capital
- Roth Capital keeps Buy on Merus after delay of cancer data
- 06/26/20 H.C. Wainwright
- Merus initiated with a Buy at H.C. Wainwright
- 05/27/20
- Fly Intel: Top five analyst downgrades
- 08:31 Today Noble Capital
- Gevo price target raised to $8.25 from $5 at Noble Capital
- 12/31/20 Noble Capital
- Gevo price target raised to $5 from $3.50 at Noble Capital
- 02/06/20 Noble Capital
- Gevo initiated with an Outperform at Noble Capital
- 01/06/21 Canaccord
- Lithium Americas price target raised to C$20 from C$11.50 at Canaccord
- 12/23/20 Stifel
- Stifel starts Lithium Americas with Buy, sees 'attractive upside'
- 12/22/20 Stifel
- Lithium Americas initiated with a Buy at Stifel
- 10/21/20 Roth Capital
- Lithium Americas downgraded to Neutral from Buy at Roth Capital
SYRS Syros Pharmaceuticals - 11/10/20 Brookline
- Syros Pharmaceuticals initiated with a Buy at Brookline
- 11/05/20 Roth Capital
- Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital
- 11/04/20
- Fly Intel: Top five analyst upgrades
- 11/04/20 H.C. Wainwright
- Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright
- 01/04/21 Lake Street
- Perion Network price target raised to $18 from $12 at Lake Street
- 12/31/20 Sidoti
- Perion Network price target raised to $14 from $12 at Sidoti
- 11/19/20
- Fly Intel: Top five analyst initiations
- 11/19/20 Roth Capital
- Perion Network initiated with a Buy at Roth Capital
- 12/04/20 Roth Capital
- Bionano Genomics downgraded to Neutral from Buy at Roth Capital
- 12/04/20 Roth Capital
- Bionano Genomics downgraded to Neutral from Buy at Roth Capital
- 09/24/20 Ladenburg
- Bionano Genomics initiated with a Buy at Ladenburg
- 04/08/20 Oppenheimer
- Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
- 06/17/20 Raymond James
- Fulton Financial upgraded to Outperform from Market Perform at Raymond James
- 06/01/20 Stephens
- Fulton Financial initiated with an Equal Weight at Stephens
- 06:10 Today Credit Suisse
- J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
- 01/06/21 Citi
- J.B. Hunt upgraded to Buy from Neutral at Citi
- 01/05/21 Stephens
- J.B. Hunt price target raised to $167 from $155 at Stephens
- 11/30/20 Deutsche Bank
- J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
- 11/10/20 DA Davidson
- eXp World Holdings price target raised to $53 from $28 at DA Davidson
- 04/20/20 Stephens
- Stephens ups CoreLogic, downgrades two others in real estate services shake-up
SRNE Sorrento Therapeutics - 07/31/20 H.C. Wainwright
- Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
- 07/20/20 Dawson James
- Sorrento antibody cocktail effort could move quickly, says Dawson James
- 05/26/20 Dawson James
- Sorrento Therapeutics initiated with a Buy at Dawson James
- 01/07/21 B. Riley Securities
- Zions Bancorp price target raised to $55 from $52 at B. Riley Securities
- 01/04/21 Barclays
- Zions Bancorp downgraded to Equal Weight with $50 target at Barclays
- 01/04/21 Barclays
- Zions Bancorp downgraded to Equal Weight from Overweight at Barclays
- 12/07/20 Evercore ISI
- Zions Bancorp upgraded to Outperform from In Line at Evercore ISI
- 01/12/21 Piper Sandler
- CareDx price target raised to $93 from $62 at Piper Sandler
- 01/04/21 Craig-Hallum
- CareDx price target raised to $94 from $66 at Craig-Hallum
- 12/17/20 BTIG
- CareDx price target raised to $80 from $55 at BTIG
- 12/10/20 Raymond James
- CareDx price target raised to $75 from $62 at Raymond James
- 16:12 Today
- Zions Bancorp reports Q4 EPS $1.66, consensus $1.02
- 10/19/20
- Zions Bancorp reports Q3 EPS $1.01, consensus 88c
- 07/20/20
- Zions Bancorp reports Q2 EPS 34c, consensus 38c
SYRS Syros Pharmaceuticals - 11/05/20
- Syros Pharmaceuticals reports Q3 EPS (43c), consensus (38c)
- 08/06/20
- Syros Pharmaceuticals reports Q2 EPS (38c), consensus (40c)
- 16:05 Today
- Perion Network sees Q4 EPS 35c-36, consensus 23c
- 12/07/20
- Perion Network raises FY20 revenue view to $310M-$315M from $290M-$300M
- 12/07/20
- Perion Network raises Q4 revenue view to $100M-$105M from $81M-$91M
- 10/28/20
- Perion Network reports Q3 EPS 21c, consensus 7c
- 16:03 Today
- Netflix sees Q1 EPS $2.97, consensus $2.10
- 16:01 Today
- Netflix reports Q4 EPS $1.19, consensus $1.39
- 13:40 Today
- Notable companies reporting after market close
- 10/20/20
- Netflix sees Q4 EPS $1.35, consensus 94c
- 08/06/20
- Merus reports Q2 EPS (54c), consensus (61c)
- 08/14/20
- Lithium Americas reports Q2 EPS (7c) vs. (7c) last year
- 16:07 Today
- J.B. Hunt reports Q4 EPS $1.44, consensus $1.30
- 10/16/20
- J.B. Hunt reports Q3 EPS $1.18, consensus $1.27
- 10/15/20
- Notable companies reporting before tomorrow's open
- 08/28/20
- Gevo says Peak Value IP sets IP portfolio at greater than $400M
- 16:34 Today
- Fulton Financial reports Q4 EPS 30c, consensus 31c
- 10/20/20
- Fulton Financial reports Q3 EPS 38c, consensus 20c
- 07/21/20
- Fulton Financial reports Q2 EPS 24c, consensus 10c
- 11/09/20
- eXp World Holdings reports Q3 EPS 20c, consensus 7c
- 08/05/20
- eXp World Holdings sees revenue to grow year-over-year in Q3 and Q4
- 08/05/20
- eXp World Holdings reports Q2 EPS 11c, consensus (1c)
- 01/11/21
- CareDx reports preliminary 2020 revenue $191.9M-$192.1M, consensus $186.75M
- 01/11/21
- CareDx reports preliminary Q4 revenue $58.4M-$58.6M, consensus $53.21M
- 10/29/20
- CareDx reports Q3 EPS 10c, consensus (6c)
- 10/07/20
- CareDx sees Q3 revenue $53M, consensus $44.68M
- 11/12/20
- Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M.
- 10/15/20
- Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M
- 08/13/20
- Bionano Genomics reports Q2 net loss ($8.0M) vs. ($7.67M) a year ago
|
Periodicals
|
FireEye (FEYE) has… FireEye (FEYE) has released a report on the SolarWinds (SWI) hack reported in early December, when the cybersecurity firm along with Microsoft (MSFT) "confirmed that a threat actor broke into the network of IT software provider SolarWinds and poisoned updates for the Orion app with malware," reported ZDNet. With this report, FireEye released a "free tool on GitHub named Azure AD Investigator that they say can help companies determine if the SolarWinds hackers (also known as UNC2452) used any of these techniques inside their network," added the ZDNet story. Reference Link ShowHide Related Items >><< - 01/06/21
- DOJ says SolarWinds cyberattack affected its system
- 12/31/20
- Microsoft says hackers viewed source code amid network intrusion
- 12/31/20
- Microsoft says no evidence systems used to attack others, customer data breach
- 12/24/20
- SolarWinds releases updates to address Supernova vulnerabilities
- 09:15 Today
- General Motors jumps 6% to $53.25 after Microsoft invests in Cruise
- 09:05 Today
- General Motors, Cruise announce long-term relationship with Microsoft
- 01/15/21
- Activision's 'COD: Black Ops: Cold War' best-selling game of 2020, says NPD
- 01/15/21
- December video game spending grew 25% y/y to $7.7B, says NPD
- 12/28/20
- FireEye director sells 50K shares of common stock
- 12/11/20
- FireEye adds Blackstone senior managing director to board as deal closes
- 12/08/20
- FireEye falls 8% to $14.26 per share after disclosing cyber attack in 8-K filing
- 12/08/20
- FireEye discloses attack by 'sophisticated cyber threat actor'
- 01/12/21 Mizuho
- FireEye price target raised to $21 from $17 at Mizuho
- 01/08/21 Morgan Stanley
- FireEye price target raised to $19 from $14 at Morgan Stanley
- 01/08/21 Goldman Sachs
- FireEye price target raised to $25 from $17 at Goldman Sachs
- 01/05/21 Piper Sandler
- FireEye price target raised to $22 from $16 at Piper Sandler
- 01/14/21 JPMorgan
- Investors with 'strong stomach for risk' should buy SolarWinds, says JPMorgan
- 01/11/21
- Fly Intel: Top five analyst downgrades
- 01/11/21 Jefferies
- SolarWinds downgraded to Hold on near-term challenges from hack at Jefferies
- 01/11/21 Barclays
- SolarWinds price target lowered to $14 from $20 at Barclays
- 09:22 Today Morgan Stanley
- Microsoft called 'a top stock for the recovery' at Morgan Stanley
- 01/13/21 KeyBanc
- Windows upside could be limited with growth skewed to consumer, says KeyBanc
- 01/12/21 Morgan Stanley
- CIO survey shows Microsoft 'dominance,' says Morgan Stanley
- 01/11/21 JPMorgan
- Microsoft in-house chip co-designed by Marvell, says JPMorgan
- 10/27/20
- SolarWinds sees 2020 EPS 98c, consensus 94c
- 10/27/20
- SolarWinds sees Q4 EPS 25c, consensus 25c
- 10/27/20
- SolarWinds reports Q3 adjusted EPS 25c, consensus 24c
- 08/06/20
- SolarWinds sees FY20 adjusted EPS 94c, consensus 86c
- 10/27/20
- Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B
- 10/27/20
- Microsoft reports Q1 EPS $1.82, consensus $1.54
- 07/22/20
- Microsoft reports Q4 EPS $1.46, consensus $1.37
- 10/27/20
- FireEye sees FY20 EPS 28c-30c, consensus 25c
- 10/27/20
- FireEye sees Q4 EPS 9c-11c, consensus 10c
- 10/27/20
- FireEye reports Q EPS 11c, consensus 7c
- 10/27/20
- Notable companies reporting after market close
- 12/21/20
- Intel sees no evidence of systems impacted by hack at SolarWinds, Bloomberg says
- 12/21/20
- SolarWinds adviser warned of cybersecurity risks in 2017, Bloomberg reports
- 12/21/20
- Security experts 'freaking out' about SolarWinds attack, Business Insider says
- 01/14/21
- IBM buying cloud computing consultant Taos Mountain, WSJ reports
- 01/13/21
- Lucasfilm partners with Ubisoft to make open-world 'Star Wars' game, Wired says
- 01/12/21
- Microsoft, others near deals for prime office space in Florida, BI reports
- 01/11/21
- Google halts campaign spending after Capitol siege, Reuters says
- 01/11/21
- FBI investigating Russian-linked postcard sent to FireEye CEO, Reuters reports
- 12/24/20
- Suspected Russian hack on agencies failed to breach CrowdStrike, Reuters reports
- 12/17/20
- Nuclear weapons agency breached amid massive espionage operation, Politico says
- 09/01/20
- Hackers test security of Trump campaign sites ahead of election, Reuters says
- 12/23/20
- Qualcomm initiation, IAC downgrade among today's top calls on Wall Street
- 12/21/20
- Analysts move to sidelines on SolarWinds following cyberattack
- 12/14/20
- Fly Intel: Wall Street's top stories for Monday
- 16:49 Today
- Fly Intel: Wall Street's top stories for Tuesday
- 12:16 Today
- Fly Intel: Wall Street's top stories at midday
- 11:53 Today
- Game On: An exclusive talk with The Game Bakers' Emeric Thoa
- 01/12/21
- Fly Intel: Wall Street's top stories for Tuesday
- 12/02/20
- Salesforce slips as Wall Street digests 'fairly outlandish' price paid for Slack
- 09/24/20
- SPACs under pressure as SEC chairman voices disclosure concerns
- 12/23/20
- Telos, Palo Alto seen among potential beneficiaries of Sunburst hack
- 12/08/20
- Fly Intel: After-Hours Movers
- 11/20/20
- Fly Intel: Wall Street's top stories for Friday
- 11/20/20
- Fly Intel: Wall Street's top stories at midday
- 11/19/20
- Fly Intel: After-Hours Movers
- 10/27/20
- Fly Intel: After-Hours Movers
- 12/17/20
- Notable open interest changes for December 17th
- 11/11/20
- Notable open interest changes for November 11th
- 10/28/20
- Notable open interest changes for October 28th
- 10/27/20
- Notable open interest changes for October 27th
- 12/28/20
- FireEye call volume above normal and directionally bullish
- 12/24/20
- Unusually active option classes on open December 24th
- 12/18/20
- FireEye call volume above normal and directionally bullish
- 12/18/20
- Unusually active option classes on open December 18th
|